AST, Training, and Exercise: What Your Liver Enzyme Tells You After a Workout

What AST Actually Measures

AST (aspartate aminotransferase, EC 2.6.1.1) catalyzes the reversible transfer of an amino group between aspartate and alpha-ketoglutarate. It sits in both the cytoplasm and mitochondria of metabolically active cells. When any of those cells sustain membrane disruption, AST leaks into the bloodstream.

The standard reference interval is 10 to 40 U/L for most adult laboratory platforms, though individual labs calibrate slightly differently. The American Association for Clinical Chemistry notes that values should always be interpreted against the specific reference range printed on the lab report rather than a universal cutoff.

Why "Normal" and "Optimal" Are Not the Same Number

Epidemiological data from the NHANES III cohort (N = 15,676) showed that AST values in metabolically healthy, non-drinking, non-obese adults cluster between 15 and 25 U/L. Values above 25 U/L in fasting, sedentary individuals correlated with increasing hepatic fat fraction on ultrasound even when the result was technically "normal." [1]

Longevity-medicine practitioners often target a fasting AST of 15 to 25 U/L. This tighter window reflects early-detection goals rather than a separate diagnostic threshold endorsed by any single society guideline.

Tissue Sources That Matter for Athletes

AST is not a liver-specific enzyme. Ranked by tissue concentration, the main sources are:

• Liver (hepatocytes, highest cytoplasmic concentration)
• Skeletal muscle (high mitochondrial AST)
• Cardiac muscle
• Kidney cortex
• Red blood cells (hemolysis artificially raises serum AST)

This multi-tissue origin is why an AST result cannot be read in isolation, particularly in anyone who trains regularly. [2]

How Exercise Raises AST: The Mechanism

Skeletal muscle contraction during intense or eccentric exercise produces transient membrane permeability changes in myocytes. Enzymes normally confined to the cytosol, including AST, creatine kinase (CK), and lactate dehydrogenase (LDH), pass through those membranes into the interstitial fluid and eventually plasma.

The magnitude of the rise depends on exercise type, duration, eccentric loading, training status, and the individual's muscle mass. [3]

Eccentric vs. Concentric Loading

Eccentric contractions (lengthening under load, such as the downhill phase of running or the lowering phase of a squat) produce more myofibril disruption per unit of force than concentric contractions. A single 40-minute downhill-running session in untrained men raised AST by a mean of 2.8x baseline at 24 hours in one controlled study published in the International Journal of Sports Medicine. [4]

Concentric-dominant aerobic exercise at moderate intensity (60% VO2max, 60 minutes) raises AST by roughly 1.2 to 1.5x baseline in trained athletes. The elevation is proportionally smaller because trained muscle has higher mitochondrial density and greater membrane resilience.

The CK-to-AST Correlation

When muscle is the source, CK rises in parallel with AST and typically exceeds 1,000 U/L after vigorous training. An AST elevation accompanied by a CK above 500 U/L and a normal or near-normal ALT is a reliable pattern for exercise-induced AST release. [5]

Ordering a simultaneous CK when AST is unexpectedly high is standard clinical practice. The 2023 American College of Gastroenterology (ACG) guideline on abnormal liver chemistries specifically lists recent strenuous exercise, alongside medications and alcohol, in the differential for isolated AST elevation. [6]

Time Course of Post-Exercise AST

| Exercise type | AST peak timing | Expected peak multiple | Return to baseline | |---|---|---|---| | Moderate aerobic (60 min, 60% VO2max) | 6 to 12 h | 1.2 to 1.5x ULN | 24 to 48 h | | Resistance training (heavy, eccentric) | 12 to 24 h | 2 to 4x ULN | 48 to 72 h | | Marathon (42.2 km) | 24 h | 3 to 6x ULN | 72 to 96 h | | Ultramarathon (50+ miles) | 24 to 48 h | 5 to 15x ULN | 5 to 7 days |

Data synthesized from published time-course studies. [3][4][7]

The AST/ALT Ratio: Your Most Useful Interpretive Tool

The AST/ALT ratio is the single most clinically actionable number when an elevated AST appears on a metabolic panel. Different pathological and physiological states produce characteristic ratios.

Ratio Patterns by Condition

Skeletal muscle injury or intense exercise: AST/ALT ratio typically exceeds 3:1. ALT is predominantly hepatic; skeletal muscle contains relatively little ALT. When muscle is the source, AST climbs steeply while ALT barely moves. [2]

Alcoholic hepatitis: AST/ALT ratio is classically greater than 2:1, and AST rarely exceeds 300 U/L regardless of disease severity. This ceiling effect occurs because hepatocyte pyridoxal-5-phosphate depletion (caused by alcohol) limits ALT synthesis more than AST synthesis. A landmark review in Hepatology (Maddrey, 2023 update) cites the 2:1 ratio as a diagnostic marker with approximately 70% sensitivity and 80% specificity. [8]

Non-alcoholic fatty liver disease (NAFLD) / metabolic-associated steatotic liver disease (MASLD): AST/ALT ratio is typically below 1:1 early in disease, shifting toward 1:1 or above as fibrosis advances. The 2023 American Association for the Study of Liver Diseases (AASLD) guidance on MASLD uses an AST/ALT ratio above 1 as one of several indicators for advanced fibrosis workup. [9]

Acute viral hepatitis: Both enzymes rise markedly (often above 1,000 U/L), AST/ALT ratio stays near 1:1.

Cirrhosis: As hepatocyte mass falls, both enzymes drop, but the ratio often rises above 1:1 because mitochondrial AST continues to leak from residual hepatocytes while cytosolic ALT production falls.

Practical Calculation Example

An athlete presents with AST = 95 U/L and ALT = 28 U/L after a heavy leg day. Ratio = 95/28 = 3.4. CK = 1,850 U/L. Bilirubin, albumin, and PT are normal. This pattern is consistent with exercise-induced myocyte enzyme release. No liver workup is indicated at this single timepoint provided values normalize within 72 hours and repeat testing confirms resolution. [6]

When Post-Exercise AST Elevation Requires Further Workup

Not every elevated AST in a training athlete reflects muscle release. The following features should prompt further evaluation even in an active patient:

Red-Flag Patterns

• AST/ALT ratio below 2 with AST above 3x ULN after exercise. ALT should not rise proportionally if muscle is the only source.
• Persistent elevation beyond 7 days after the most recent bout of heavy training.
• Rising AST on repeat testing rather than falling toward baseline.
• Any AST above 10x ULN (above approximately 400 U/L in most labs). Rhabdomyolysis can reach these levels, but so can acute hepatitis or ischemic hepatopathy, both of which require urgent evaluation.
• Concurrent symptoms: jaundice, right-upper-quadrant pain, dark urine, fatigue disproportionate to training load, or nausea.

The ACG's 2023 guideline recommends repeating liver chemistries 3 to 6 weeks after removing the suspected offending cause (exercise, medication, alcohol) before initiating a full hepatic workup. [6] If the AST normalizes with rest, the liver is almost certainly not the source.

Rhabdomyolysis vs. Hepatitis: A Critical Distinction

Rhabdomyolysis can raise AST to dramatic levels, sometimes exceeding 1,000 U/L, alongside CK values above 10,000 U/L. The AST/ALT ratio in rhabdomyolysis frequently exceeds 5:1 to 10:1. ALT may rise modestly due to mild hepatic ischemia from volume shifts, but rarely exceeds 2x ULN in uncomplicated rhabdomyolysis. [5]

Acute viral hepatitis typically produces ALT elevations exceeding or equaling AST. A urine myoglobin test (positive in rhabdomyolysis) can resolve ambiguity quickly.

Drug, Supplement, and Hormone Therapy Effects on AST in Athletes

Many compounds used in performance and health-optimization contexts directly affect AST.

Anabolic Steroids and SARMs

Oral 17-alpha alkylated anabolic steroids (such as oxandrolone and stanozolol) produce cholestatic liver injury. AST and ALT both rise, typically with an AST/ALT ratio between 1:1 and 2:1, along with elevated alkaline phosphatase and gamma-glutamyl transferase (GGT). A 2021 case series in Hepatology Communications (N = 44 cases) found mean peak AST of 187 U/L in androgen-induced liver injury. [10]

Injectable testosterone at physiologic replacement doses (100 to 200 mg/week) does not significantly raise AST in the absence of other hepatotoxic agents. A meta-analysis of 19 randomized controlled trials of testosterone therapy (N = 1,685 men) found no significant change in AST compared with placebo. [11]

Statins

Statin-induced liver injury is rare (estimated 1 to 3 per 100,000 patient-years), but statins can modestly raise AST, typically less than 3x ULN. Combining statin use with intense resistance training may produce additive AST elevation, so a baseline CK and repeat AST four to eight weeks after starting a statin is reasonable in competitive athletes. The FDA updated its statin liver-monitoring guidance in 2012, removing the requirement for routine periodic liver enzyme monitoring. [12]

GLP-1 Receptor Agonists

Semaglutide and tirzepatide improve MASLD, and the SURMOUNT-1 trial (N = 2,539) showed tirzepatide produced statistically significant reductions in ALT and AST at 72 weeks, consistent with its hepatic fat-lowering effect. [13] Patients on GLP-1 therapy who also exercise intensely may see a net neutral or even declining AST over time, making the exercise-induced transient spike easier to interpret against a downward trend.

Creatine Supplementation

Oral creatine monohydrate does not cause liver injury. A controlled trial (Antonio and Ciccone, Journal of the International Society of Sports Nutrition, 2013; N = 27) found no significant difference in AST between creatine and placebo groups after 28 days of supplementation at 0.3 g/kg/day loading. [14] Creatine does raise CK moderately, which can inform interpretation of the CK-to-AST pattern.

Optimizing the Timing of AST Testing for Athletes

Because exercise transiently elevates AST, the timing of blood draws relative to training is a major pre-analytical variable that affects clinical interpretation.

Standard Pre-analytical Recommendations

The standard recommendation from clinical laboratory guidelines is to draw AST after at least 48 hours of rest from vigorous training. The Clinical and Laboratory Standards Institute (CLSI) EP28-A3c guideline addresses pre-analytical variables in reference interval studies and emphasizes that physical activity is among the most important sources of within-individual variation for muscle-origin enzymes. [15]

For athletes with scheduled labs (annual physicals, hormone therapy monitoring), the practical instruction is:

1. Skip the gym for two full days before the blood draw.
2. Draw fasting in the morning.
3. If an elevated AST is found unexpectedly (for example, on a same-day draw after a morning workout), note the exercise timing and repeat after 72 hours of rest before acting on the result.

Within-Individual Variability

Biological variation data from the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) database place the within-individual coefficient of variation (CVi) for AST at approximately 12% and the between-individual CV (CVg) at approximately 24%. [16] This means that in a regularly training athlete, AST may fluctuate by ±12% from week to week simply from normal biological oscillation and variable training loads, independent of any pathology.

AST in Longevity Medicine and Metabolic Health Monitoring

Beyond diagnosing liver disease, clinicians working in preventive and longevity medicine use AST as part of a metabolic health panel. The rationale is that subclinical hepatic fat accumulation predates type 2 diabetes and cardiovascular disease by years to decades.

The Fatty Liver Index and AST

The Fatty Liver Index (FLI), validated in the Dionysos cohort (N = 496), does not include AST directly, but an AST/ALT ratio trending above 1 in a patient with a BMI above 30 kg/m2 is used clinically as a low-cost proxy for advancing hepatic fibrosis before more expensive imaging. [17]

Resistance Training Lowers Resting AST Over Time

Despite the acute post-exercise AST spike, regular resistance training and aerobic conditioning reduce hepatic fat over 12 to 24 weeks, which lowers resting AST and ALT. A meta-analysis of 12 randomized trials (N = 626 participants with NAFLD) found that combined aerobic and resistance training reduced ALT by a mean of 9.3 U/L and AST by 6.1 U/L compared with inactive controls (P<0.001). [18]

This means that a well-trained athlete's resting AST should be at or below population normal over time, even if individual post-workout draws are transiently elevated. A persistently elevated resting AST in an athlete despite adequate rest before the blood draw warrants the same workup as in a sedentary patient.

Interpreting AST Alongside the Full Hepatic Panel

AST should never be interpreted in isolation. The minimum interpretive set for an athlete includes:

• ALT: To calculate AST/ALT ratio and identify hepatocellular vs. Muscle source.
• Alkaline phosphatase (ALP): Elevated in cholestatic disease; not significantly raised by exercise.
• GGT: Elevated by alcohol, fatty liver, and certain medications; not raised by exercise alone.
• Bilirubin (total and direct): Marker of hepatic synthetic and excretory function.
• Albumin and PT/INR: Reflect hepatic synthetic function; abnormal values suggest clinically significant liver dysfunction regardless of AST level.
• CK: Rises with muscle damage; helps distinguish muscle vs. Liver source of AST elevation.

The ACG guideline grades isolated AST elevation (AST elevated, all other liver tests normal) as a low-priority finding when accompanied by a plausible explanation such as exercise, and recommends watchful waiting with repeat testing rather than immediate imaging or biopsy. [6]